E Fund Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
|
|||||
|
2025
Q1 | $178K | Buy |
|
|||||
|
2024
Q4 | $125K | Sell |
|
|||||
|
2024
Q3 | $181K | Sell |
|
|||||
|
2024
Q2 | $175K | Sell |
|
|||||
|
2024
Q1 | $377K | Buy |
|
|||||
|
2023
Q4 | $307K | Buy |
|
|||||
|
2023
Q3 | $294K | Sell |
|
|||||
|
2023
Q2 | $369K | Buy |
|
|||||
|
2023
Q1 | $389K | Buy |
|
|||||
|
2022
Q4 | $462K | Buy |
|
|||||
|
2022
Q3 | $446K | Sell |
|
|||||
|
2022
Q2 | $470K | Buy |
|
|||||
|
2022
Q1 | $271K | Buy |
|
|||||
|
2021
Q4 | $206K | Buy |
|
|||||
|
2021
Q3 | $163K | Buy |
|
|||||
|
2021
Q1 | $112K | Buy |
|